These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21719162)

  • 1. Synthesis of novel 1,2,5-trisubstituted benzimidazoles as potential antitumor agents.
    Abonia R; Cortés E; Insuasty B; Quiroga J; Nogueras M; Cobo J
    Eur J Med Chem; 2011 Sep; 46(9):4062-70. PubMed ID: 21719162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization and biological evaluation of some 16β-azolyl-3β-amino-5α-androstane derivatives as potential anticancer agents.
    Guo H; Zhang G; Zhang T; He X; Wu Z; Xiao Y; Pan Y; Qiu G; Liu P; Hu X
    Eur J Med Chem; 2011 Sep; 46(9):3662-74. PubMed ID: 21641694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, structural characterization, and in vitro antitumor activity of novel N-(6-chloro-1,1-dioxo-1,4,2-benzodithiazin-3-yl)arylsulfonamides.
    Brzozowski Z; Saczewski F; Sławiński J; Bednarski PJ; Grünert R; Gdaniec M
    Bioorg Med Chem; 2007 Apr; 15(7):2560-72. PubMed ID: 17306551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzimidazole bearing oxadiazole and triazolo-thiadiazoles nucleus: design and synthesis as anticancer agents.
    Husain A; Rashid M; Mishra R; Parveen S; Shin DS; Kumar D
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5438-44. PubMed ID: 22840417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anticancer activity of some novel 2-substituted benzimidazole derivatives.
    Refaat HM
    Eur J Med Chem; 2010 Jul; 45(7):2949-56. PubMed ID: 20399544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate.
    Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
    Eur J Med Chem; 2006 Apr; 41(4):539-47. PubMed ID: 16545495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents.
    Insuasty B; Tigreros A; Orozco F; Quiroga J; Abonía R; Nogueras M; Sanchez A; Cobo J
    Bioorg Med Chem; 2010 Jul; 18(14):4965-74. PubMed ID: 20594863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization and evaluation of benzimidazole derivative and its precursors as inhibitors of MDA-MB-231 human breast cancer cell proliferation.
    Thimmegowda NR; Nanjunda Swamy S; Kumar CS; Kumar YC; Chandrappa S; Yip GW; Rangappa KS
    Bioorg Med Chem Lett; 2008 Jan; 18(1):432-5. PubMed ID: 17981032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of benzimidazoles bearing oxadiazole nucleus as anticancer agents.
    Rashid M; Husain A; Mishra R
    Eur J Med Chem; 2012 Aug; 54():855-66. PubMed ID: 22608854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and cytotoxic evaluation of novel 2-(4-(2,2,2-trifluoroethoxy)-3-methylpyridin-2-ylthio)-1H-benzo[d]imidazole derivatives.
    Ranganatha SR; Kavitha CV; Vinaya K; Prasanna DS; Chandrappa S; Raghavan SC; Rangappa KS
    Arch Pharm Res; 2009 Oct; 32(10):1335-43. PubMed ID: 19898794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro cytotoxic evaluation of some thiazolylbenzimidazole derivatives.
    Luo Y; Xiao F; Qian S; Lu W; Yang B
    Eur J Med Chem; 2011 Jan; 46(1):417-22. PubMed ID: 21115212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, spectroscopy (IR, multinuclear NMR, ESI-MS), diffraction, density functional study and in vitro antiproliferative activity of pyrazole-beta-diketone dihalotin(IV) compounds on 5 melanoma cell lines.
    Pettinari C; Caruso F; Zaffaroni N; Villa R; Marchetti F; Pettinari R; Phillips C; Tanski J; Rossi M
    J Inorg Biochem; 2006 Jan; 100(1):58-69. PubMed ID: 16313961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity.
    Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J
    Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antitumor activity of β-carboline 3-(substituted-carbohydrazide) derivatives.
    Barbosa VA; Formagio AS; Savariz FC; Foglio MA; Spindola HM; de Carvalho JE; Meyer E; Sarragiotto MH
    Bioorg Med Chem; 2011 Nov; 19(21):6400-8. PubMed ID: 21944971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and toxicity towards normal and cancer cell lines of benzimidazolequinones containing fused aromatic rings and 2-aromatic ring substituents.
    Moriarty E; Carr M; Bonham S; Carty MP; Aldabbagh F
    Eur J Med Chem; 2010 Sep; 45(9):3762-9. PubMed ID: 20605274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anticancer activity of a novel class of flavonoids: 2,4-diarylchromane[4,3-d]-delta(1,9b)-1,2,3-thiadiazolines.
    Ying H; Hu Y; He Q; Li R; Yang B
    Eur J Med Chem; 2007 Feb; 42(2):226-34. PubMed ID: 17137679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, spectroscopic characterization and antiproliferative evaluation in vitro of novel Schiff bases related to benzimidazoles.
    Hranjec M; Starčević K; Pavelić SK; Lučin P; Pavelić K; Karminski Zamola G
    Eur J Med Chem; 2011 Jun; 46(6):2274-9. PubMed ID: 21439689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells.
    Xia Y; Fan CD; Zhao BX; Zhao J; Shin DS; Miao JY
    Eur J Med Chem; 2008 Nov; 43(11):2347-53. PubMed ID: 18313806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of novel 4-(1H-benzimidazol-2-yl)benzene-1,3-diols and their cytotoxic activity against human cancer cell lines.
    Karpińka MM; Matysiak J; Niewiadomy A
    Arch Pharm Res; 2011 Oct; 34(10):1639-47. PubMed ID: 22076764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSAR modeling, synthesis and bioassay of diverse leukemia RPMI-8226 cell line active agents.
    Katritzky AR; Girgis AS; Slavov S; Tala SR; Stoyanova-Slavova I
    Eur J Med Chem; 2010 Nov; 45(11):5183-99. PubMed ID: 20843586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.